Skip to content
Screener

Genpact G Commitment fee (in percentage)

Commitment fee (in percentage) at other companies

Lightwave Logic, Inc. logo
Lightwave Logic, Inc.LWLG
$46.27K+42.9%
Hooker Furnishings Corporation logo
Hooker Furnishings CorporationHOFT
1.8%0.0pp
Neuropace, Inc. logo
Neuropace, Inc.NPCE
10%
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$17.49M
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$17.49M
Artiva Biotherapeutics, Inc. logo
Artiva Biotherapeutics, Inc.ARTV
$0.01

Other financials

Income statement

See full
Revenue$1.3B+7.1%
Gross profit$490.3M+8.9%
Operating income$192.9M+7.5%
Net income$145.7M+9.8%
EPS (diluted)$0.86+14.7%

Balance sheet

See full
Cash & equivalents$517.4M-22.0%
Total debt$1.4B+21.6%
Total equity$2.6B+0.7%
Total assets$5.4B+2.0%

Cash flow

See full
Operating cash flow$72.4M-59.2%
CapEx$13.9M-37.3%
Free cash flow$58.5M-62.3%

Valuation

See full
Market cap$5.98B-19.0%
Enterprise value$6.87B-12.8%
P/E10.3×-3.4×
P/S1.1×-0.4×

Profitability

See full
Gross margin36.5%+0.8pp
Operating margin14.8%-0.1pp
Net margin11.1%+0.2pp
FCF margin10.9%-0.6pp

Returns & leverage

See full
Return on equity22.4%+0.6pp
Debt / equity0.5×+0.1×
Current ratio+0.5×

Where this comes from

Reported directly by Genpact in its filing.

Tagged under the XBRL concept g:UnutilizedAmountOfLineOfCreditFacilityCommitmentFeePercentage.

The source filing: Genpact’s 10-Q, filed May 8, 2026.

Filed
May 8, 2026, 11:42 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001398659-26-000010

b.A fund-based and non-fund based revolving credit facility of $650,000, which the Company obtained by entering into an amended and restated credit agreement (the "2022 Credit Agreement") with Genpact USA, Genpact Global Holdings (Bermuda) Limited ("GGH") and Genpact Luxembourg, each wholly owned subsidiaries of the Company (Genpact Luxembourg, Genpact USA and GGH, collectively, the "Borrowers"), as borrowers, Wells Fargo, National Association ("Wells Fargo"), as administrative agent, swingline lender and issuing bank, and the lenders and other parties thereto on December 13, 2022. The term loan and revolving credit facility under the 2022 Credit Agreement expire on December 13, 2027. Borrowings under the 2022 Credit Agreement bear interest at a rate equal to, at the election of the Company, either Adjusted Term SOFR (which is the rate per annum equal to (a) Term SOFR (the forward-looking secured overnight financing rate) plus (b) a Term SOFR Adjustment of 0.10% per annum, but in no case lower than 0.0%) plus an applicable margin equal to 1.375% per annum or a base rate plus an applicable margin equal to 0.375% per annum. The unutilized amount on the revolving credit facility under the 2022 Credit Agreement bore a commitment fee of 0.20% as of December 31, 2025 and March 31, 2026. As of December 31, 2025 and March 31, 2026, a total of $1,257 and $1,257, respectively, was utilized, of which $0 and $0, respectively, constituted funded drawdown and $1,257 and $1,257, respectively, constituted non-funded drawdown. The 2022 Credit Agreement contains certain customary covenants, including a maximum leverage covenant and a minimum interest coverage ratio. As of December 31, 2025 and March 31, 2026, the Company was in compliance with the financial covenants of the 2022 Credit Agreement.

Item 1. Unaudited Consolidated Financial Statements

FAQ

What is Genpact's commitment fee (in percentage)?
Genpact (G) reported commitment fee (in percentage) of $0 in Q1 2026.
How has Genpact's commitment fee (in percentage) changed year-over-year?
Genpact's commitment fee (in percentage) increased by 300.0% year-over-year, from $0 to $0.
What does commitment fee (in percentage) mean?
Commitment fee (in percentage) as reported by GENPACT LIMITED.

Ask your AI about Genpact's commitment fee (in percentage).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude